is semaglutide hard on the kidneys just got FDA-approved for kidney disease. This changes everything. January 2025. FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in type 2 diabetes with CKD. This Semaglutide lowers UACR in overweight
Description
If side effects are significant at a new dose, staying at the current level for an additional four weeks or longer before attempting to increase again is the right approach
More longitudinal studies, adequately considering possible confounding factors, are needed to clarify these relationships and identify modifiable risk factors for targeted interventions
Semaglutide, 3 Month Supply Get a discount on your Compounded Semaglutide with our 3-month quarterly plan
You have not achieved your weight loss goals through diet and physical activity alone
Nav Persaud, Canada Research Chair in Health Justice and a staff physician at St
Provider review and approval required
